What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Alzheimer's disease
- Disease
Her primary areas of study are Alzheimer's disease, Neuroscience, Dementia, Disease and Cognition.
Her Alzheimer's disease study integrates concerns from other disciplines, such as Biomarker, Neuroimaging and Cognitive decline.
Her Dementia research is multidisciplinary, incorporating perspectives in Gerontology, Predictive value of tests, Imaging biomarker, Age of onset and Tauopathy.
Her Disease study combines topics in areas such as Psychiatry, Clinical trial and Intensive care medicine.
Her research in Cognition intersects with topics in Alzheimer's disease biomarkers and Cohort study.
Reisa A. Sperling combines subjects such as Placebo and Oncology with her study of Internal medicine.
Her most cited work include:
- Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (4395 citations)
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease (2656 citations)
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease (2229 citations)
What are the main themes of her work throughout her whole career to date?
Reisa A. Sperling mostly deals with Disease, Neuroscience, Internal medicine, Alzheimer's disease and Dementia.
Her work in Disease addresses subjects such as Cognition, which are connected to disciplines such as Clinical psychology, Audiology and Developmental psychology.
Her Neuroscience study which covers Amyloid that intersects with Positron emission tomography.
Her Internal medicine research is multidisciplinary, relying on both Endocrinology and Oncology.
Her work carried out in the field of Alzheimer's disease brings together such families of science as Magnetic resonance imaging and Neuroimaging.
Reisa A. Sperling works mostly in the field of Dementia, limiting it down to topics relating to Gerontology and, in certain cases, Activities of daily living, as a part of the same area of interest.
She most often published in these fields:
- Disease (44.49%)
- Neuroscience (37.49%)
- Internal medicine (35.12%)
What were the highlights of her more recent work (between 2018-2021)?
- Disease (44.49%)
- Internal medicine (35.12%)
- Cognitive decline (29.76%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Disease, Internal medicine, Cognitive decline, Cognition and Amyloid.
Her Disease research is classified as research in Pathology.
Her Dementia, Alzheimer's disease, Biomarker and Neurodegeneration investigations are all subjects of Internal medicine research.
Her work in Alzheimer's disease addresses issues such as Cohort study, which are connected to fields such as Depression.
Reisa A. Sperling usually deals with Cognition and limits it to topics linked to Clinical trial and Odds ratio.
As a part of the same scientific family, Reisa A. Sperling mostly works in the field of Amyloid, focusing on Neuroscience and, on occasion, Tauopathy.
Between 2018 and 2021, her most popular works were:
- Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. (376 citations)
- Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease : A Longitudinal Study (220 citations)
- Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease : A Longitudinal Study (220 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Alzheimer's disease
The scientist’s investigation covers issues in Internal medicine, Alzheimer's disease, Cognition, Cognitive decline and Dementia.
Her study in the field of Cohort, Apolipoprotein E and Pittsburgh compound B also crosses realms of Clinical neurology.
Her Alzheimer's disease study is concerned with the larger field of Pathology.
Her Cognition study incorporates themes from Audiology, Disease, Family history and Depression.
Her Cognitive decline research incorporates themes from Alzheimer's Disease Neuroimaging Initiative, Sex characteristics, Cardiology, Cognitive test and Amyloid.
Her research in Dementia intersects with topics in Temporal lobe, Asymptomatic, Entorhinal cortex, Pediatrics and Tauopathy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
